Evidence map›Paper›PMID 35919857›Full record

ArticleVeterinary research forum : an international quarterly journal2022

The

Murat Cengiz, Pinar Sahinturk, Gulce Hepbostanci, Halis Akalin, Songul Sonal

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Veterinary research forum : an international quarterly journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. A Multidrug-ResistantVeterinary sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Murat CengizDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Uludag University, Nilufer, Turkiye.
Pinar SahinturkInstitute of Health Science, Uludag University, Nilufer, Turkiye.
Gulce HepbostanciInstitute of Health Science, Uludag University, Nilufer, Turkiye.
Halis AkalinDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Uludag University, Nilufer, Turkiye.
Songul SonalDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Uludag University, Nilufer, Turkiye.
Bursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the high prevalence of multi-drug resistant bacteria, combination therapy is an efficient choice for treatment of infections caused by highly resistant strains. In this study, the efficacy of ceftiofur plus danofloxacin combination was investigated against resistant

Indexed as

CeftiofurDanofloxacinEscherichia coliIn vitro activityMulti-drug resistance

Identifiers

PMID35919857
PMCPMC9340295
OpenAlexW4289786932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.